Cytoreductive Surgery and HIPEC in First or Secondary Platinum-resistant Recurrent Ovarian Epithelial Cancer

NCT03220932 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

132

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Epithelial Cancer

Interventions

PROCEDURE: Cytoreductive surgery combined with HIPEC
DRUG: Chemotherapy and bevacizumab (CT-BEV)

Sponsor

Hospices Civils de Lyon